17.49
price up icon0.58%   0.10
after-market Dopo l'orario di chiusura: 17.49
loading
Precedente Chiudi:
$17.39
Aprire:
$16.71
Volume 24 ore:
636.84K
Relative Volume:
0.40
Capitalizzazione di mercato:
$108.62M
Reddito:
-
Utile/perdita netta:
$-121.02M
Rapporto P/E:
-1.5533
EPS:
-11.26
Flusso di cassa netto:
$-114.09M
1 W Prestazione:
-34.42%
1M Prestazione:
+136.99%
6M Prestazione:
+38.81%
1 anno Prestazione:
-97.25%
Intervallo 1D:
Value
$16.36
$17.58
Intervallo di 1 settimana:
Value
$16.36
$25.77
Portata 52W:
Value
$7.31
$672.00

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile

Name
Nome
Tonix Pharmaceuticals Holding Corp
Name
Telefono
212-980-9155
Name
Indirizzo
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
Dipendente
0
Name
Cinguettio
@TONIXPharma
Name
Prossima data di guadagno
2025-03-17
Name
Ultimi documenti SEC
Name
TNXP's Discussions on Twitter

Confronta TNXP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
17.49 108.62M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 125.55B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 67.78B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 36.24B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.99B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.77B 3.81B -644.79M -669.77M -6.24

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-04-18 Iniziato Noble Capital Markets Outperform
2019-04-18 Aggiornamento ROTH Capital Neutral → Buy
2017-08-18 Aggiornamento ROTH Capital Neutral → Buy
2016-09-07 Downgrade ROTH Capital Buy → Neutral
2016-02-17 Reiterato Oppenheimer Outperform
2015-11-04 Iniziato Cantor Fitzgerald Buy
2015-06-12 Iniziato Oppenheimer Outperform
2015-02-17 Reiterato ROTH Capital Buy
2014-09-29 Reiterato ROTH Capital Buy
Mostra tutto

Tonix Pharmaceuticals Holding Corp Borsa (TNXP) Ultime notizie

pulisher
Apr 02, 2025

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference - GlobeNewswire

Apr 02, 2025
pulisher
Apr 01, 2025

Tonix Pharma stock rises following TONIX ONE launch - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharma stock rises following TONIX ONE launch By Investing.com - Investing.com UK

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals launches migraine management platform - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals launches migraine management platform By Investing.com - Investing.com Canada

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals Launches TONIX ONE™, a - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Game-Changing Digital Platform Transforms How Patients Track and Treat Migraines - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Revolutionary Non-Opioid Pain Drug Could Transform Fibromyalgia Treatment by 2025 - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc. - Bluefield Daily Telegraph

Mar 29, 2025
pulisher
Mar 27, 2025

(TNXP) Long Term Investment Analysis - Stock Traders Daily

Mar 27, 2025
pulisher
Mar 27, 2025

Tonix Pharmaceuticals Announces Presentation at the - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Fast-Tracked Fibromyalgia Treatment: Tonix Showcases Breakthrough Pain Drug Data Before FDA Decision - StockTitan

Mar 27, 2025
pulisher
Mar 26, 2025

2 Stocks Riding the Biotech Surge With Major Catalysts Ahead - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years - Seeking Alpha

Mar 26, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Tonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is Problematic (TNXP) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Pharma Frenzy: Volatility Ignites Biotech Sector - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga

Mar 25, 2025
pulisher
Mar 24, 2025

Tonix advances fibromyalgia drug, eyes Q4 2025 launch By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment; Shares Up - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix advances fibromyalgia drug, eyes Q4 2025 launch - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals stock soars on FDA update By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals stock soars on FDA update - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharma’s TNX-102 SL Advances in FDA Process - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Tonix Pharmaceuticals Announces that FDA Will Not Require - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

First New Fibromyalgia Treatment in 15 Years Advances: FDA Expedites TNX-102 SL Review - Stock Titan

Mar 24, 2025
pulisher
Mar 22, 2025

Tonix Pharmaceuticals Stock Dives After Q4 Earnings Miss, But Retail’s Feeling Bullish - MSN

Mar 22, 2025
pulisher
Mar 21, 2025

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread - BioSpace

Mar 21, 2025
pulisher
Mar 20, 2025

New Single-Dose Mpox Vaccine Outperforms Existing Options as Cases Surge Worldwide - StockTitan

Mar 20, 2025
pulisher
Mar 19, 2025

Tonix Pharma stock drops after Q4 revenue miss (TNXP:NASDAQ) - Seeking Alpha

Mar 19, 2025
pulisher
Mar 19, 2025

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Tonix Pharmaceuticals Reports 2024 Financial Results and Pipeline Progress - TipRanks

Mar 19, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals stock tumbles on earnings miss - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharma earnings missed by $5.86, revenue fell short of estimates - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals stock tumbles on earnings miss By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals Holding Corp. SEC 10-K Report - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals 8-K Filing Analysis - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2024 - MarketScreener

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Tonix Secures Path to First New Fibromyalgia Drug in 15 Years with $98.8M War Chest - StockTitan

Mar 18, 2025
pulisher
Mar 17, 2025

Learn to Evaluate (TNXP) using the Charts - Stock Traders Daily

Mar 17, 2025
pulisher
Mar 16, 2025

* Tonix pharmaceuticals announces 1-for-10 reverse stock split - Reuters

Mar 16, 2025
pulisher
Mar 14, 2025

Tonix Pharmaceuticals secures MCDC grant to advance next-gen Mpox & Smallpox vaccine development - Proactive Investors USA

Mar 14, 2025
pulisher
Mar 14, 2025

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing - The Manila Times

Mar 14, 2025
pulisher
Mar 13, 2025

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025 - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Major FDA Decision Looms: Tonix's Revolutionary Fibromyalgia Treatment Could End 15-Year Innovation Drought - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target - BioSpace

Mar 12, 2025

Tonix Pharmaceuticals Holding Corp Azioni (TNXP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):